维普中文期刊产品整合服务
9篇 您的检索式:作者名="Kehmeier"
    题名 作者 年代 出处 被引量
1TNF-α,myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention显示文摘Kehmeier ES Lepper W Kropp M 0,,:1
2Cellular steady-state levels of 'high risk' but not 'low risk' human papillomavirus (HPV)E6 pro- Leins are increased by inhibition of proteasome-dependent degrada- Lion independent of their p53- and E6AP-binding capabilities 显示文摘Kehmeier E Rtihl H Voland B 2002Virology2002,299,1:1
319-year-old boy with congenital ven- tricular septal defect and increased pressures in right heart catheterization显示文摘Jussofie J Kehmeier ES 2015Dtsch Med Wochenschr2015,140,2:1
4TNF-alpha,myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention显示文摘Kehmeier ES Lepper W Kropp M 2012Clin Res Cardiol2012,101,10:1
5Cellular steady state levels of 'high risk'but not'low risk'human papillomavi- rus (HPV) E6 proteins are increased by inhibition of prote- asome dependent degradation independent of their p53 and E6AP binding capabilities 显示文摘Kehmeier E Riibl H Voland B 2002Virology2002,299,1:1
6Cellular steady-state levels of ' high risk' but not ' low risk' human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities显示文摘Kehmeier E Ruhl H Voland B 2002Virology2002,299,1:1
7Cellular steady-statelevels of 'high risk' but not 'low risk' human papillomavirus (HPV) E6 protein are increased by inhibition of proteason-dependent degradation independent of their p53- and E6AP-binding capabilities 显示文摘Kehmeier E Ruhl H Voland B 2002Virology2002,299,:1
8TNF-a,myocardial perfusion and function in patients with ST-segment elevation myocardial infarction and primary percutaneous coronary intervention显示文摘Kehmeier ES Lepper W Kropp M 2012Clin Res Cardiol2012,101,10:1
9Initial clinical experience using the Echo Navigator~-system during structural heart disease interventions显示文摘AIM: To present our initial clinical experience using this innovative software solution for guidance of percutaneous structural heart disease interventions.METHODS: Left atrial appendage, atrial septal defect and paravalvular leak closure, transaortic valve repair and Mitra Clip procedures were performed in the catheter laboratory under fluoroscopic and echocardiographic guidance. The two-dimensional and three-dimensional images generated by the transesophageal echocardiography probe were interfaced with the fluoroscopic images in real-time using the Echo Navigator-system.RESULTS:The application of the novel image fusion technology was safe and led to a better appreciation of multimodality imaging guidance due to improved visualization of the complex relationship between catheter devices and anatomical structures.CONCLUSION:The Echo Navigator-system is a feasible and safe tool for guidance of interventional procedures in structural heart disease.This innovative technology may improve confidence of interventional cardiologists in targeting and positioning interventional devices in order to increase safety,accuracy,and efficacy of percutaneous interventions in the catheter laboratory.Jan Balzer Tobias Zeus Katharina Hellhammer Verena Veulemans Silke Eschenhagen Eva Kehmeier Christian Meyer Tienush Rassaf Malte Kelm 2015World Journal of Cardiology2015,7,9:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费